JMP Securities downgraded Deciphera to Market Perform from Outperform after the company entered into an agreement to be acquired by Ono Pharmaceutical for $25.60 per share.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential